Published in Osteoarthritis Cartilage on November 11, 2014
Study to Prevent Cartilage Damage Following Acute Knee Injury. | NCT00332254
Charge based intra-cartilage delivery of single dose dexamethasone using Avidin nano-carriers suppresses cytokine-induced catabolism long term. Osteoarthritis Cartilage (2015) 1.46
Intra-articular dexamethasone to inhibit the development of post-traumatic osteoarthritis. J Orthop Res (2017) 0.76
Molecular changes indicative of cartilage degeneration and osteoarthritis development in patients with anterior cruciate ligament injury. BMC Musculoskelet Disord (2016) 0.75
Systems Based Study of the Therapeutic Potential of Small Charged Molecules for the Inhibition of IL-1 Mediated Cartilage Degradation. PLoS One (2016) 0.75
Cartilage-targeting drug delivery: can electrostatic interactions help? Nat Rev Rheumatol (2017) 0.75
Synthetic nanoscale electrostatic particles as growth factor carriers for cartilage repair. Bioeng Transl Med (2016) 0.75
The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys (1961) 19.31
Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta (1986) 13.69
Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol (2010) 5.14
Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal Biochem (1988) 4.68
Posttraumatic osteoarthritis: a first estimate of incidence, prevalence, and burden of disease. J Orthop Trauma (2006) 3.37
Post-traumatic osteoarthritis: improved understanding and opportunities for early intervention. J Orthop Res (2011) 2.63
Prevalence of degenerative morphological changes in the joints of the lower extremity. Osteoarthritis Cartilage (1997) 2.22
Decreased lubricin concentrations and markers of joint inflammation in the synovial fluid of patients with anterior cruciate ligament injury. Arthritis Rheum (2008) 2.04
Osteoarthritis - an untreatable disease? Nat Rev Drug Discov (2005) 1.93
Aggrecan protects cartilage collagen from proteolytic cleavage. J Biol Chem (2003) 1.93
New developments in osteoarthritis. Posttraumatic osteoarthritis: pathogenesis and pharmacological treatment options. Arthritis Res Ther (2010) 1.84
Inhibitory effects of insulin-like growth factor-1 and osteogenic protein-1 on fibronectin fragment- and interleukin-1beta-stimulated matrix metalloproteinase-13 expression in human chondrocytes. J Biol Chem (2003) 1.78
Intraarticular inflammatory cytokines in acute anterior cruciate ligament injured knee. Knee (2003) 1.69
Changes in serum and synovial fluid biomarkers after acute injury (NCT00332254). Arthritis Res Ther (2010) 1.61
Oxidative stress inhibits insulin-like growth factor-I induction of chondrocyte proteoglycan synthesis through differential regulation of phosphatidylinositol 3-Kinase-Akt and MEK-ERK MAPK signaling pathways. J Biol Chem (2009) 1.60
Mechanical compression of cartilage explants induces multiple time-dependent gene expression patterns and involves intracellular calcium and cyclic AMP. J Biol Chem (2004) 1.56
Reduction in the chondrocyte response to insulin-like growth factor 1 in aging and osteoarthritis: studies in a non-human primate model of naturally occurring disease. Arthritis Rheum (2000) 1.54
Age-related decline in chondrocyte response to insulin-like growth factor-I: the role of growth factor binding proteins. J Orthop Res (1997) 1.54
The natural history of the anterior cruciate ligament-deficient knee. Changes in synovial fluid cytokine and keratan sulfate concentrations. Am J Sports Med (1998) 1.51
Differential effects of bFGF and IGF-I on matrix metabolism in calf and adult bovine cartilage explants. Arch Biochem Biophys (1994) 1.49
Detection of nitrotyrosine in aging and osteoarthritic cartilage: Correlation of oxidative damage with the presence of interleukin-1beta and with chondrocyte resistance to insulin-like growth factor 1. Arthritis Rheum (2002) 1.49
Insulin-like growth factor 1 can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines. Biochem J (1989) 1.43
Pharmacologic therapy for osteoarthritis--the era of disease modification. Nat Rev Rheumatol (2010) 1.34
Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT00332254). Osteoarthritis Cartilage (2012) 1.30
Mechanical injury potentiates proteoglycan catabolism induced by interleukin-6 with soluble interleukin-6 receptor and tumor necrosis factor alpha in immature bovine and adult human articular cartilage. Arthritis Rheum (2009) 1.27
Growth factor responsiveness of human articular chondrocytes in aging and development. Arthritis Rheum (1995) 1.27
Analysis of ADAMTS4 and MT4-MMP indicates that both are involved in aggrecanolysis in interleukin-1-treated bovine cartilage. Osteoarthritis Cartilage (2005) 1.24
Progress in intra-articular therapy. Nat Rev Rheumatol (2013) 1.24
Effects of short-term glucocorticoid treatment on changes in cartilage matrix degradation and chondrocyte gene expression induced by mechanical injury and inflammatory cytokines. Arthritis Res Ther (2011) 1.19
Changes in biochemical parameters after anterior cruciate ligament injury. Int Orthop (2005) 1.17
Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes. J Immunol (1995) 1.17
Dose-dependent effects of corticosteroids on the expression of matrix-related genes in normal and cytokine-treated articular chondrocytes. Inflamm Res (2003) 1.12
Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis. Arthritis Rheumatol (2014) 1.07
Cartilage and bone markers and inflammatory cytokines are increased in synovial fluid in the acute phase of knee injury (hemarthrosis)--a cross-sectional analysis. Osteoarthritis Cartilage (2012) 1.04
Dexamethasone induces apoptosis in proliferative chondrocytes through activation of caspases and suppression of the Akt-phosphatidylinositol 3'-kinase signaling pathway. Endocrinology (2004) 1.03
Prevention of chondrocyte apoptosis. J Bone Joint Surg Am (2001) 1.03
Effects of dexamethasone on the functional properties of cartilage explants during long-term culture. Am J Sports Med (2009) 1.01
Dexamethasone enhances SOX9 expression in chondrocytes. J Endocrinol (2001) 0.99
Chondrocyte apoptosis induced by collagen degradation: inhibition by caspase inhibitors and IGF-1. J Orthop Res (2004) 0.99
Tissue-specific actions of glucocorticoids on apoptosis: a double-edged sword. Cells (2013) 0.98
Intraarticular injection of heparin-binding insulin-like growth factor 1 sustains delivery of insulin-like growth factor 1 to cartilage through binding to chondroitin sulfate. Arthritis Rheum (2010) 0.96
Dexamethasone inhibits inflammation and cartilage damage in a new model of post-traumatic osteoarthritis. J Orthop Res (2013) 0.91
Avidin as a model for charge driven transport into cartilage and drug delivery for treating early stage post-traumatic osteoarthritis. Biomaterials (2013) 0.91
Effects of non-steroidal antiinflammatory drugs and dexamethasone on the activity and expression of matrix metalloproteinase-1, matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by bovine articular chondrocytes. Osteoarthritis Cartilage (2001) 0.90
Glucocorticoids induce senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53/p21 pathway: in vivo and in vitro evidence. Ann Rheum Dis (2013) 0.90
Glucocorticoid effects on chondrogenesis, differentiation and apoptosis in the murine ATDC5 chondrocyte cell line. J Endocrinol (2002) 0.89
Pharmacological disruption of insulin-like growth factor 1 binding to IGF-binding proteins restores anabolic responses in human osteoarthritic chondrocytes. Arthritis Res Ther (2004) 0.88
Effect of bisphosphonates on viability, proliferation, and dexamethasone-induced apoptosis of articular chondrocytes. Ann Rheum Dis (2002) 0.87
The use of intra-articular corticosteroids in the horse: what is known on a scientific basis? Equine Vet J (2010) 0.87
Effects of IL-6 and its soluble receptor on proteoglycan synthesis and NO release by human articular chondrocytes: comparison with IL-1. Modulation by dexamethasone. Matrix Biol (1999) 0.86
IGF-1 does not moderate the time-dependent transcriptional patterns of key homeostatic genes induced by sustained compression of bovine cartilage. Osteoarthritis Cartilage (2009) 0.81
Effects of alendronate and pamidronate on cultured rat metatarsal bones: failure to prevent dexamethasone-induced growth retardation. Bone (2008) 0.78
Distal femoral shaft fracture: a complication of endoscopic anterior cruciate ligament reconstruction--a case report. Am J Sports Med (1998) 0.76
Moderate dynamic compression inhibits pro-catabolic response of cartilage to mechanical injury, tumor necrosis factor-α and interleukin-6, but accentuates degradation above a strain threshold. Osteoarthritis Cartilage (2013) 0.92
IL-10 reduces apoptosis and extracellular matrix degradation after injurious compression of mature articular cartilage. Osteoarthritis Cartilage (2016) 0.77
Impact of a daily exercise dose on knee joint cartilage - a systematic review and meta-analysis of randomized controlled trials in healthy animals. Osteoarthritis Cartilage (2017) 0.75